Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Price:
90.64
USD
3.93%
Market Cap:
$6.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
Equinor ASA
F:DNQA
|
NO |
|
L
|
Levi Strauss & Co
F:LV2B
|
US |
|
W
|
Western Alliance Bancorp
XBER:WEA
|
US |
|
Limbach Holdings Inc
F:J4B
|
US |
|
Iperionx Ltd
F:30Z
|
US |
|
Elicio Therapeutics Inc
F:9HA
|
US |
|
Aegon NV
OTC:AEGOF
|
NL |
Wall St Price Targets
RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc
Wall Street analysts forecast RYTM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RYTM is 140.96 USD with a low forecast of 106.05 USD and a high forecast of 166.95 USD.
Lowest Forecast
Price Target
106.05
USD
17% Upside
Average Forecast
Price Target
140.96
USD
56% Upside
Highest Forecast
Price Target
166.95
USD
84% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYTM's stock price target?
Price Target
140.96
USD
140.96
USD
According to Wall Street analysts, the average 1-year price target for RYTM is 140.96 USD with a low forecast of 106.05 USD and a high forecast of 166.95 USD.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.
